Nanovery Ltd
At Nanovery, their cutting-edge DNA nanorobots are revolutionising the biotechnology landscape. As pioneers in nucleic acid nanorobotics (NANs), our platform is the first to provide comprehensive solutions for RNA therapeutic analysis and biomarker quantification. This innovation elevates research precision and simplifies testing protocols.
Their mission is to make the testing processes as simple as possible to drive advancements in biotech research. Nanovery's NANs technology is not just part of biotechnology's future; it is actively shaping it, ensuring their partners stay at the forefront of innovation.
Pictura Bio
Pictura Bio’s groundbreaking diagnostic platform was born out of a unique combination of medical and technical expertise in virology, biophysics and microscopy from the company’s co-founders, Dr Nicole Robb and Nicolas Shiaelis.
Sekisui
BioProduction by Sekisui offers contract development and manufacturing services for the biopharmaceutical industry. Our facility in the UK has over 40 years of fermentation and purification experience with enzymes and proteins as our focus. We offer expertise in bioprocess development, scale up and manufacturing of enzymes, plasmids, antibody fragments and other proteins. We offer ISO 9001, ISO 13485 and GMP manufacturing quality standards for your custom production. We are in the process of a $19M expansion of our GMP facility for drug substance manufacturing which will complete in 2023.